Watch history unfold on our dedicated CX 2021 on-demand channel and relive the decisive debates of the event, whilst also benefiting from up to 16 reciprocal EU/US CME credits.
Highlighted from Day 2 was the long-awaited call to change agency recommendations regarding paclitaxel use in peripheral interventions, spearheaded by Thomas Zeller’s debate. In the presence of regulatory authorities the CX audience overwhelmingly voted in agreement with Zeller to concur paclitaxel is safe.
CX is privileged to be the platform to host these high-impact findings and invite you to watch on-demand to witness pivotal verdicts unfold first-hand. To see the full conclusion of the paclitaxel findings and access the entire content from the event you can register via the button below. You can also view the full programme here.
